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Two 67 kDa proteins adsorbed to membranes in the presence of Ca 2t have been purified to homogeneity 
from pig lung using conventional procedures, followed by calcium-dependent affinity chromatography on 
polyacrylamide-immobilized phosphatidylserine. The two proteins were, respectively, excluded (67E) and 
retained (67R) on the column in the presence of Ca 2f . On the basis of amino acid composition and isoelec- 
tric point, 67R was identified as 67 kDa calelectrin/calcimedin, whereas 67E could be differentiated from 
albumin, calregulin, 67 kDa fragment of protein kinase C and surfactant-associated proteins. Only 67R was 
slightly phosphorylated by protein kinase C, reacted with an antibody raised against 32.5 kDa endonexin 
and inhibited pig pancreas phospholipase Al in a way similar to that of lipocortin or endonexin. These data 
bring further support to the view that inhibition of phospholipase AZ by lipocortin or other related proteins 
involves interaction with the lipid/water interface. They also provide evidence for a new kind of Ca2+-bind- 
ing protein (67E), whose role still remains to be determined. 
Ca2+-binding protein; Lipocortin; Phospholipase AZ; Phosphatidylserine; (Lung) 
1. INTRODtiCTION 
The anti-inflammatory action of steroids is 
thought to involve induction of proteins able to 
inhibit PLA2, a key enzyme in the biosynthesis 
of icosanoids and of platelet-activating factor (l- 
0-alkyl-2-acetyl-sn-glycero-3-phosphocholine or 
PAF-acether) [ 11. The anti-phospholipase A2 ac- 
tivity of these proteins, called lipocortins [2-41, 
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ty chromatography on phosphatidylserine 
could also be regulated by phosphorylation in- 
volving either serine/threonine protein kinases [5] 
or oncogene/growth factor tyrosine kinases [6,7]. 
Greater knowledge of these proteins was recent- 
ly obtained, mainly through data on their amino 
acid sequence [3,8,9]. These revealed the existence 
of two different lipocortins detected respectively as 
a 35-37 kDa monomer (LC I), or as a 
heterotetramer containing two copies of a 36 kDa 
chain displaying 50% homology with LC I, 
together with two copies of a 10 kDa chain related 
to SlOO proteins (LC II) [lo]. Moreover, com- 
plementary studies revealed that LCs 1 and II are 
identical to calpactins II and I, respectively, de- 
fined by their ability to bind to polymerized actin 
and to anionic phospholipids in a Ca2+-dependent 
manner [ 111. Finally, some degree of homology 
has also been found between calpactins/LCs and a 
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group of other Ca’+- and phospholipid-binding 
proteins, which contain a 17 amino acid residue 
consensus sequence [12]. These include 32.5 kDa 
endonexin, also referred to as protein II, 35 kDa 
and 67 kDa calelectrins (the latter also called pro- 
tein III), which are able to modulate aggregation 
of chromaffin secretory granules (other name: 
chromobinding [13]). In the same group, other 
Ca*+-binding proteins (calcimedins) seem to be 
identical to calelectrins and to 68-73 kDa protein 
from lymphocytes (reviews [14,15]). These obser- 
vations led us to emphasize some possible common 
properties of these related proteins. In this respect, 
we recently found that endonexin from bovine 
liver displays an anti-PLA2 activity very similar to 
that of LC, as studied in an in vitro test [16]. The 
present study extends the observation to the case of 
67 kDa calelectrin/calcimedin from pig lung and 
gives further support to the view that anti-PLAz 
activity of these proteins is closely related to their 
phospholipid binding properties. In addition, a 
new type of Ca*+-binding protein without affinity 
for phospholipid is described. 
2. MATERIALS AND METHODS 
All chemicals used were from Sigma (St Louis, 
MO). LC I was obtained from pig lung according 
to De et al. [17]. During the same procedure, frac- 
tions from an AcA 44 column containing 67 kDa 
proteins were pooled and submitted to affinity 
chromatography on a polyacrylamide-immobilized 
phosphatidylserine column [ 181. Polyacrylamide 
gel electrophoresis in the presence of SDS was per- 
formed under reducing conditions according to 
Laemmli [19]. Isoelectric points of the proteins 
were determined by analytical focusing in 
polyacrylamide gel using an LKB 2117 multiphor 
I1 apparatus and ampholine polyacrylamide gel 
plates (pH 3.5-9.5). Amino acid analysis was car- 
ried out according to [16] and protein determined 
as in [20]. 
Rabbit polyclonal antibody was raised against 
bovine liver endonexin [16] by conventional pro- 
cedures. Immune blotting was performed using an 
LKB 2117-250 Novablot electrophoretic transfer 
kit according to [21]. 
In vitro phosphorylation of proteins was deter- 
mined using protein kinase C purified from rat 
brain according to [22]. Autorad_iography of dried 
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Fig. 1. Affinity chromatography on polyacrylamide- 
immobilized phosphatidylserine of 67 kDa proteins (a) 
and of pig serum albumin (b). 67E and 67R were eluted 
from the column with buffer (100 mM KCl, 10 mM 
Hepes, pH 7.4) containing 1 mM CaClz or 5 mM 
EGTA, respectively. (Inset) SDS-PAGE of various 
fractions detected by silver staining. (a) Lane c, 67 kDa 
proteins from AcA 44 column chromatography; lanes 
7,13, fractions 7 and 13 from polyacrylamide- 
immobilized phosphatidylserine column. (b) Lane c, pig 
serum albumin; lanes 4,12, fractions 4 and 12 from 
polyacrylamide-immobilized phosphatidylserine 
column. 
gels was performed at - 8O”C, using Kodak X- 
OMat films. 
Anti-phospholipase A2 activity was assayed as in 
[ 161 using [3H]oleic acid-labelled Escherichia coli 
membranes (3 x lo5 dpm/nmol phospholipid) as 
substrate of pancreatic phospholipase AZ. 
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3. RESULTS 
Proteins extracted with EGTA from pig lung 
membranes previously sedimented in the presence 
of Ca2+ were gel filtered onto an AcA 44 column. 
Fractions eluting with an apparent molecular mass 
of 63 kDa appeared homogeneous upon SDS- 
PAGE, the estimated molecular mass being in that 
case 67 kDa. However, two different proteins 
could then be resolved from this pool using 
Ca2+-dependent affinity chromatography on 
polyacrylamide-immobilized phosphatidylserine. 
As shown in fig.la, two proteins displaying iden- 
tical molecular masses upon SDS-PAGE were 
recovered in roughly equal amounts (0.731 and 
0.741 mg, respectively, from 100 g tissue) in the 
flow-through fraction (67E) and in the EGTA 
eluate (67R). Such an effect of the phosphatidyl- 
serine chromatography appeared rather specific, 
since pig serum albumin was not adsorbed onto the 
column (fig. lb). 
reported in table 1, some significant differences 
were noted for other less abundant amino acids 
such as Ser, Met, Ile, Leu, Tyr, Lys and Arg. Table 
1 also lists the amino acid composition of porcine 
serum albumin, which differed from the two pro- 
teins. Two attempts to sequence intact protein 67R 
remained unsuccessful, suggesting that the N- 
terminal end is probably blocked, as already found 
for endonexin [16]. 
As shown in fig.2, 67R reacted with a polyclonal 
antibody raised in rabbit against bovine endonex- 
in, whereas 67E was not recognized. In vitro 
phosphorylation by protein kinase C was also 
checked. As illustrated in fig.3, 67R, but not 67E, 
was slightly phosphorylated in the presence of 
purified protein kinase C. In contrast to lipocortin 
I, which became heavily labelled (fig.3), 67R 
phosphorylation was hardly dependent on the 
presence of phosphatidylserine and Ca’+, sug- 
gesting that some phospholipid might remain ad- 
sorbed onto the protein. 
The isoelectric point of 67R and 67E was 6.4 and As shown in fig.4, protein 67R promoted a dose- 
below 4.9, respectively. Moreover, amino acid dependent inhibition of PLA2 similar to that of 
analysis revealed some striking differences between LC, whereas 67E was inactive. Maximal inhibition 
the two proteins, especially in the level of Glx (11.8 was 50 and 60% for 67R and LC I, respectively. 
and 23.3% in 67R and 67E, respectively). As On a molar basis, 50% inhibition of PLA2 activity 
Table 1 
Amino acid composition of 67 kDa proteins from pig lung and of pig serum albumin 
Amino acid 67R 67E Pig serum albumin 
mol% Molar ratio mol% Molar ratio mol% Molar ratio 
Asx 9.6 60 1.1 68 9.6 51 
Thr 5.1 32 6.0 37 5.7 30 
Ser 8.9 56 12.7 78 5.7 30 
GlX 11.8 74 23.3 143 15.1 80 
G1Y 15.0 94 13.4 -82 4.2 22 
Ala 7.0 44 8.0 49 9.6 51 
Val 3.8 24 4.6 28 5.8 31 
Met 2.5 16 0.5 3 0.2 1 
Be 5.3 33 2.9 18 3.6 19 
Leu 9.1 57 5.2 32 11.9 63 
Tyr 4.1 26 2.0 12 4.7 25 
Phe 3.3 21 2.3 14 5.3 28 
His 2.1 13 2.6 16 3.2 17 
Lys 6.8 43 3.9 24 10.4 55 
Arg 5.6 35 1.8 11 5.1 27 
Values are extrapolated to zero time from two analyses (3 for 67E) performed after 20 h 
hydrolysis and one analysis after 70 h hydrolysis 
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Fig.2. Immune blotting experiments with anti-endonexin 
shown on the left. 
antiserum. (a) SDS-PAGE slab stained with silver 
reagents; lane 1, 32.5 kDa liver endonexin; lane 2, 
67 kDa R; lane 3, 67 kDa E. (b) Immune blot of a 
second gel identical to that of panel a after reaction with 
antiserum to 32.5 kDa endonexin and peroxidase- 
labelled anti-immunoglobulins. With 3-amino-Pethyl- 
carbazole, a red insoluble precipitate characterizes the 
antigen-antibody complex. Molecular mass (kDa) is 
was attained at 250 nM and 316 nM of 67R and identical, amino acid composition has also been 
LC, respectively. This is essentially in the same found for 32.5 kDa calelectrin/endonexin [16,25] 
order as the values previously reported for en- as well as for 35 kDa calelectrin/calcimedin 
donexin [ 161. [28,29]. All these proteins share in common with 
4. DISCUSSION 
In addition to the two LCs recognized so far [23] 
and to endonexin [16], our data provide evidence 
for a 67 kDa protein (67R) able to inhibit PLAz, 
using [3H]oleic acid-labelled E. co/i membranes as 
a substrate. One common feature of these four 
proteins is their ability to bind anionic 
phospholipids such as phosphatidylserine [ 16,241. 
The amino acid composition of 67R is very similar 
to that of 67 kDa calelectrin [13,25], 67 kDa 
calcimedin [26] and 68-73 kDa protein from lym- 
phocytes [27], which are probably identical pro- 
teins [14]. However, 67R displayed some 
significant differences in the level of Gly and Lys, 
which were, respectively, higher and lower com- 
pared to other literature data. A similar, if not 
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Fig.3. Phosphorylation of purified 67 kDa proteins by 
protein kinase C in vitro. Autoradiograms of the SDS- 
mass (kDa) indicated on the right for each panel. 
PAGE of the reaction mixtures resulting from the 
incubation of protein kinase C (5 units) in the presence 
of [r-32P] ATP and 1 pg of each protein with and 
without the phospholipid-calcium mixture; lanes 1 and 
2, respectively. Phosphorylated material at higher 
apparent molecular size than 67 kDa proteins was 
attributed to self-phosphorylated protein kinase C 
(84 kDa). 1 unit of protein kinase C activity was defined 
as 1 pmol 32P incorporated per min at 3O”C, into histone 
III-S type as a standard protein substrate. Molecular 
Fig.4. Inhibition of phospholipase A2 activity by 67 kDa 
proteins (X-X, 67R; H ,67E) and the lipocortin I 
(M). Results are means of three experiments. 
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LCs several repeats of a 17 amino acid residue con- 
sensus sequence, which probably explains the im- 
munological cross-reactivity existing between these 
proteins [30] and illustrated herein. So, our data 
allow us to identify 67R as calelectrin/calcimedin. 
Considering the common features of these 
various proteins, one can propose that the 
mechanism of PLAz inhibition probably involves 
some steric hindrance at the lipid/water interface, 
following their adsorption onto anionic 
phospholipids. A similar proposal was recently put 
forward by Davidson et al. [31], who also de- 
scribed a 73 kDa protein from bovine lung able to 
inhibit PLAz in a similar in vitro assay. Further 
studies are required to establish any relationship 
between 67R and this 73 kDa protein which was 
not further characterized [31]. 
Therefore, the number of Ca’+-binding proteins 
including LCs, endonexin and calelectrin, able to 
inhibit PLA2 in a non-specific manner is rapidly 
growing. It thus appears necessary to identify 
which ones are controlled by glucocorticoids, 
whose anti-inflammatory action seems to depend 
on PLA2 inhibition [32]. On the other hand, the 
anti-PLA2 activity of these proteins might also be 
an epiphenomenon simply reflecting their ability to 
adsorb onto phospholipids and not necessarily 
related to their biological function, which still re- 
mains obscure [ 15,291. 
The anti-PLA2 activity of lipocortin has been 
shown to be regulated by phosphorylation [32]. 
This is probably not the case for 67R, which was 
revealed as a poor substrate for protein kinase C. 
As recently shown by Touqui et al. [33], platelets 
contain, in addition to LC, a protein eluting at 
around 67 kDa upon molecular sieving on a TSK- 
G2000 column, whose activity is not modulated by 
protein kinase C activation. It is thus tempting to 
suggest some similarity if not identity between that 
platelet protein and the 67R protein from lung. 
In contrast, the newly identified, glutamic acid- 
rich 67E Ca2+-binding protein strongly differs 
from the protein family mentioned above. On the 
basis of amino acid composition, 67E is also dif- 
ferent from albumin, calregulin [34], surfactant- 
associated proteins [35] as well as from a pro- 
teolytic cleavage product of protein kinase C iden- 
tified in various tissues [36,37]. Moreover, the 
67 kDa fragment of protein kinase C contains the 
catalytic site and can be (auto)phosphorylated, 
which does not appear from our phosphorylation 
experiments. 
It must be recalled that 67 kDa calcimedin exists 
as a doublet, each protein of the pair displaying 
different expression depending on the tissue [29]. 
Since the phospholipid-binding properties of 
calcimedin were not previously checked, we sug- 
gest that the calcimedin doublet might correspond 
to the 67R and 67E identified here. So 67E appears 
as a new type of Ca2+-binding proteins attaching to 
some membrane component different from 
phospholipids. Studies are now in progress to iden- 
tify membrane target sites involved in this interac- 
tion as well as any possible biochemical or 
biological function of 67E. 
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